gefitinib has been researched along with ziprasidone in 3 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (ziprasidone) | Trials (ziprasidone) | Recent Studies (post-2010) (ziprasidone) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 1,068 | 254 | 362 |
Protein | Taxonomy | gefitinib (IC50) | ziprasidone (IC50) |
---|---|---|---|
D(2) dopamine receptor | Homo sapiens (human) | 0.005 | |
Aspartate aminotransferase, cytoplasmic | Homo sapiens (human) | 5.39 | |
D | Rattus norvegicus (Norway rat) | 0.1514 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1514 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1514 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1514 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.1514 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.011 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0004 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.011 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.011 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.2301 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for gefitinib and ziprasidone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for gefitinib and ziprasidone
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |